General DEBRA research invests in Topadur to advance small-molecule therapies for dystrophic Epidermolysis bullosaBy Healthcare Propulsion StaffOctober 28, 20260 DEBRA Research gGmbH, a global non-profit organization dedicated to advancing research and drug development for Epidermolysis bullosa (EB), and Topadur…